High-throughput dynamic BH3 profiling may quickly and accurately predict effective therapies in solid tumors

Abstract

Effective treatments might be identified by rapidly profiling drug sensitivities in patient biopsies from solid tumors.

Document Details

• Document Type: Pub Defense Publication
• Publication Date: Jun 16, 2020
• Source ID: 10.1126/scisignal.aay1451

Entities

People

• Alaba Sotayo
• Andrew J Aguirre
• Anthony Letai
• David Cocozziello
• Elizaveta Lavrova
• Eman Ahmed
• Emily Su
• Ewa Sicinska
• James M. Cleary
• Jean J. Zhao
• Jennifer L Guerriero
• Jeremy Ryan
• Jing Ni
• Kelley Mcqueeney
• Kimmie Ng
• Marissa S. Pioso
• Otari Chipashvili
• Patrick D Bhola
• Timothy Hagan

Organizations

• Broad Institute
• Dana–Farber Cancer Institute
• Harvard Medical School
• National Institutes of Health
• United States Department of Defense

Tags

Fields of Study

• Chemistry

Readers

• Computational Fluid Dynamics (CFD)
• Mental Health of Military Veterans with Posttraumatic Stress Disorder (PTSD): Risk Factors, Prevalence, Symptoms, and Treatment.
• Oncology and Biomarker-Based Cancer Detection.